HuGE Literature Finder
Records 1-30
|
A comprehensive analysis of somatic alterations in Chinese ovarian cancer patients.
Scientific reports 2021 Jan 11 (1): 387. Zhang Yingli, Shi Xiaoliang, Zhang Jiejie, Chen Xi, Zhang Peng, Liu Angen, Zhu T |
|
Investigation of catechol-o-methyltransferase (COMT) Gene
Journal of the Turkish German Gynecological Association 2021 Jan . Abaoglu Ipek Yagmur, Güleç Yilmaz Seda, Akdeniz Fatma Tuba, Attar Rukset, Barut Zerrin, Dalan Altay Burak, Isbir Turg |
|
Performance of In Silico Prediction Tools for the Detection of Germline Copy Number Variations in Cancer Predisposition Genes in 4208 Female Index Patients with Familial Breast and Ovarian Cancer.
Cancers 2021 Jan 13 (1): . Lepkes Louisa, Kayali Mohamad, Blümcke Britta, Weber Jonas, Suszynska Malwina, Schmidt Sandra, Borde Julika, Klonowska Katarzyna, Wappenschmidt Barbara, Hauke Jan, Kozlowski Piotr, Schmutzler Rita K, Hahnen Eric, Ernst Corin |
|
Potentially functional variants of HBEGF and ITPR3 in GnRH signaling pathway genes predict survival of non-small cell lung cancer patients.
Translational research : the journal of laboratory and clinical medicine 2021 Jan . Wu Yufeng, Liu Zhensheng, Tang Dongfang, Liu Hongliang, Luo Sheng, Stinchcombe Thomas E, Glass Carolyn, Su Li, Lin Lijuan, Christiani David C, Wang Qiming, Wei Qing |
|
Relationship between
Molecular and clinical oncology 2021 Jan 14 (1): 15. Moscatello Carmelo, Di Nicola Marta, Veschi Serena, Di Gregorio Patrizia, Cianchetti Ettore, Stuppia Liborio, Battista Pasquale, Cama Alessandro, Curia Maria Cristina, Aceto Gitana Mar |
|
Novel candidates of pathogenic variants of the BRCA1 and BRCA2 genes from a dataset of 3,552 Japanese whole genomes (3.5KJPNv2).
PloS one 2021 16 (1): e0236907. Tokunaga Hideki, Iida Keita, Hozawa Atsushi, Ogishima Soichi, Watanabe Yoh, Shigeta Shogo, Shimada Muneaki, Yamaguchi-Kabata Yumi, Tadaka Shu, Katsuoka Fumiki, Ito Shin, Kumada Kazuki, Hamanaka Yohei, Fuse Nobuo, Kinoshita Kengo, Yamamoto Masayuki, Yaegashi Nobuo, Yasuda J |
|
The Association of Polymorphisms in Base Excision Repair Genes with Ovarian Cancer Susceptibility in Chinese Women: A Two-Center Case-Control Study.
Journal of Cancer 2021 12 (1): 264-269. Zhang Mingyao, Zhao Zhiguang, Chen Sailing, Liang Zongwen, Zhu Jiawei, Zhao Manman, Xu Chaoyi, He Jing, Duan Ping, Zhang An |
|
Breast cancer associated pathogenic variants among women 61?years and older with triple negative breast cancer.
Journal of geriatric oncology 2020 Dec . Chávarri-Guerra Yanin, Marcum Catherine A, Hendricks Carolyn B, Wilbur Deborah, Cescon Terrence, Hake Christopher, Abugattas Julio, Rodriguez Yenni, Villarreal-Garza Cynthia, Yang Kai, Cervantes Aleck, Sand Sharon, Castillo Danielle, Herzog Joseph, Mokhnatkin Janet, Sedrak Mina S, Soto-Perez-de-Celis Enrique, Weitzel Jeffrey |
|
GSTP1 and ABCB1 Polymorphisms Predicting Toxicities and Clinical Management on Carboplatin and Paclitaxel-Based Chemotherapy in Ovarian Cancer.
Clinical and translational science 2020 Dec . Ferracini Amanda Canato, Lopes-Aguiar Leisa, Lourenço Gustavo Jacob, Yoshida Adriana, Lima Carmen Silva Passos, Sarian Luis Otávio, Derchain Sophie, Kroetz Deanna L, Mazzola Priscila Ga |
|
Whole-exome sequencing of non-BRCA1/BRCA2 mutation carrier cases at high-risk for hereditary breast/ovarian cancer.
Human mutation 2020 Dec . Felicio Paula S, Grasel Rebeca S, Campacci Natalia, de Paula Andre E, Galvão Henrique C R, Torrezan Giovana T, Sabato Cristina S, Fernandes Gabriela C, Souza Cristiano P, Michelli Rodrigo D, Andrade Carlos E, Barros Bruna Durães de Figueiredo, Matsushita Marcus M, Revil Timothée, Ragoussis Jiannis, Couch Fergus J, Hart Steven N, Reis Rui M, Melendez Matias E, Tonin Patricia N, Carraro Dirce M, Palmero Edenir |
|
Association between tumor mutation burden and immune infiltration in ovarian cancer.
International immunopharmacology 2020 Nov 107126. Fan Suzhen, Gao Xiang, Qin Qiaohong, Li Hongyu, Yuan Zhongfu, Zhao Shuj |
|
Comprehensive Gene Mutation Profiling of Circulating Tumor DNA in Ovarian Cancer: Its Pathological and Prognostic Impact.
Cancers 2020 Nov 12 (11): . Noguchi Tomoko, Iwahashi Naoyuki, Sakai Kazuko, Matsuda Kaho, Matsukawa Hitomi, Toujima Saori, Nishio Kazuto, Ino Kazuhi |
|
Genetically predicted circulating protein biomarkers and ovarian cancer risk.
Gynecologic oncology 2020 Nov . Considine Daniel P C, Jia Guochong, Shu Xiang, Schildkraut Joellen M, Pharoah Paul D P, Zheng Wei, Kar Siddhartha P, |
|
Genotype-first approach to the detection of hereditary breast and ovarian cancer risk, and effects of risk disclosure to biobank participants.
European journal of human genetics : EJHG 2020 Nov . Leitsalu Liis, Palover Marili, Sikka Timo Tõnis, Reigo Anu, Kals Mart, Pärn Kalle, Nikopensius Tiit, Esko Tõnu, Metspalu Andres, Padrik Peeter, Tõnisson Nee |
|
Glycolytic phenotypes in an evaluation of ovarian carcinoma based on carcinogenesis and BRCA mutation.
European journal of radiology 2020 Nov 133 109391. Park Sohyun, Kim Tae-Sung, Lim Myong Cheol, Seo Sang-Soo, Kang Sokbom, Kim Seok-Ki, Yoo Chong Woo, Park Sang-Yo |
|
Impact of BRCA1/2 Mutations on the Efficacy of Secondary Cytoreductive Surgery.
Annals of surgical oncology 2020 Nov . Estati Felipe Leonardo, Pirolli Rafaela, de Alencar Viviane Teixeira Loiola, Ribeiro Adriana Regina Gonçalves, Formiga Maria Nirvana, Torrezan Giovana Tardin, Carraro Dirce Maria, Guimarães Andrea Paiva Gadelha, Baiocchi Glauco, da Costa Alexandre André Balieiro Anastác |
|
Implications of venous thromboembolism GWAS reported genetic makeup in the clinical outcome of ovarian cancer patients.
The pharmacogenomics journal 2020 Nov . Tavares Valéria, Pinto Ricardo, Assis Joana, Coelho Sara, Brandão Mariana, Alves Sara, Pereira Deolinda, Medeiros R |
|
Analysis of 11 candidate genes in 849 adult patients with suspected hereditary cancer predisposition.
Genes, chromosomes & cancer 2020 Oct . Cavaillé Mathias, Uhrhammer Nancy, Privat Maud, Ponelle-Chachuat Flora, Gay-Bellile Mathilde, Lepage Mathis, Molnar Ioana, Viala Sandrine, Bidet Yannick, Bignon Yves-Je |
|
BRCA1 and BRCA2 genes mutations among high risk breast cancer patients in Jordan.
Scientific reports 2020 Oct 10 (1): 17573. Abu-Helalah Munir, Azab Belal, Mubaidin Rasmi, Ali Dema, Jafar Hanan, Alshraideh Hussam, Drou Nizar, Awidi Abdal |
|
Feedback of extended panel sequencing in 1,530 patients referred for suspicion of hereditary predisposition to adult cancers.
Clinical genetics 2020 Oct . Cavaillé Mathias, Uhrhammer Nancy, Privat Maud, Ponelle-Chachuat Flora, Gay-Bellile Mathilde, Lepage Mathis, Viala Sandrine, Bidet Yannick, Bignon Yves-Je |
|
Incidence of contralateral and ipsilateral breast cancers and prognosis in BRCA1/2 pathogenic variant carriers based on the Japanese HBOC Consortium registration.
Journal of human genetics 2020 Oct . Yoshimura Akiyo, Yokoyama Shiro, Iwata Hiroji, Takaiso Nobue, Nomizu Tadashi, Arai Masami, Nakamura Sei |
|
Rare Germline Genetic Variants and the Risks of Epithelial Ovarian Cancer.
Cancers 2020 Oct 12 (10): . Pavanello Marina, Chan Isaac Hy, Ariff Amir, Pharoah Paul Dp, Gayther Simon A, Ramus Susan |
|
The relationship between BRCA-associated breast cancer and age factors: an analysis of the Japanese HBOC consortium database.
Journal of human genetics 2020 Oct . Okano Maiko, Nomizu Tadashi, Tachibana Kazunoshin, Nagatsuka Miki, Matsuzaki Masami, Katagata Naoto, Ohtake Toru, Yokoyama Shiro, Arai Masami, Nakamura Sei |
|
A Retrospective Analysis of the Relationship Between the Result of BRCA1/2 Genetic Testing and Surgical Method Selection in Japan.
Clinical breast cancer 2020 Aug . Inuzuka Mayuko, Watanabe Chie, Yokoyama Shiro, Kuwayama Takashi, Akashi-Tanaka Sadako, Arai Masami, Nakamura Seigo, |
|
Association of Molecular Genetic Markers of TP53, MDM2, and CDKN1A Genes with Progression-Free Survival of Patients with Ovarian Cancer after Platinum-Based Chemotherapy.
Bulletin of experimental biology and medicine 2020 Aug 169 (4): 486-490. Zavarykina T M, Tyulyandina A S, Khokhlova S V, Khabas G N, Asaturova A V, Nosova Yu A, Brenner P K, Kapralova M A, Atkarskaya M V, Khodyrev D S, Burdennyi A M, Loginov V I, Stenina M B, Sukhikh G |
|
Prognostic Significance of the MAD1L1 1673 G: A Polymorphism in Ovarian Adenocarcinomas.
Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 2020 May 73 (5): . Bandala-Jacques Antonio, Hernández-Cruz Irwin A, Castro-Hernández Clementina, Díaz-Chávez José, Arriaga-Canon Cristian, Barquet-Muñoz Salim A, Prada-Ortega Diddier G, Cantú-de León David, Herrera Luis |
|
Identification of KIF23 as a prognostic signature for ovarian cancer based on large-scale sampling and clinical validation.
American journal of translational research 2020 12 (9): 4955-4976. Hu Yuexin, Zheng Mingjun, Wang Caixia, Wang Shuang, Gou Rui, Liu Ouxuan, Li Xiao, Liu Juanjuan, Lin B |
|
MassArray analysis of genomic susceptibility variants in ovarian cancer.
Scientific reports 2020 12 10 (1): 21101. Verma Sonali, Sharma Indu, Sharma Varun, Bhat Amrita, Shah Ruchi, Bhat Gh Rasool, Sharma Bhanu, Bakshi Divya, Nagpal Ashna, Wakhloo Ajay, Bhat Audesh, Kumar Rake |
|
Pathogenic Heteroplasmic Somatic Mitochondrial DNA Mutation Confers Platinum-Resistance and Recurrence of High-Grade Serous Ovarian Cancer.
Cancer management and research 2020 12 11085-11093. Ni Jing, Wang Yan, Cheng Xianzhong, Teng Fang, Wang Congyang, Han Suping, Chen Xiaoxiang, Guo Wenw |
|
Single nucleotide polymorphism of transforming growth factor-ß1 and interleukin-6 as risk factors for ovarian cancer.
Central-European journal of immunology 2020 45 (3): 267-275. Ahmed Amira Ben, Zidi Sabrina, Almawi Wassim, Ghazouani Ezzeddine, Mezlini Amel, Loueslati Besma Yacoubi, Stayoussef Mou |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 19, 2021
- Content source: